×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CORT – corcept therapeutics incorporated (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CORT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/26
06:16 pm
cort
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT
Low
Report
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Corcept Therapeutics Incorporated Investors to Secure Counsel Before Important Deadline in Securities Class Action – CORT
3/26
05:22 pm
cort
Onco360® Has Been Selected as the National Pharmacy Partner for LIFYORLI™ (relacorilant) [Yahoo! Finance]
Neutral
Report
Onco360® Has Been Selected as the National Pharmacy Partner for LIFYORLI™ (relacorilant) [Yahoo! Finance]
3/26
04:42 pm
cort
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
Low
Report
CORT ALERT: Hagens Berman Alerts Corcept Therapeutics (CORT) Investors to Securities Class Action Following FDA Rejection and Federal Court Patent Loss
3/26
01:44 pm
cort
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Low
Report
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
3/26
11:28 am
cort
Corcept Therapeutics (CORT) had its price target raised by Canaccord Genuity Group Inc. from $100.00 to $110.00. They now have a "buy" rating on the stock.
Low
Report
Corcept Therapeutics (CORT) had its price target raised by Canaccord Genuity Group Inc. from $100.00 to $110.00. They now have a "buy" rating on the stock.
3/26
10:00 am
cort
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Corcept Therapeutics Incorporated of Class Action Lawsuit and Upcoming Deadlines - CORT
3/26
09:00 am
cort
Corcept Therapeutics (CORT) was upgraded by Wolfe Research from "underperform" to "peer perform".
Medium
Report
Corcept Therapeutics (CORT) was upgraded by Wolfe Research from "underperform" to "peer perform".
3/26
05:49 am
cort
Corcept Therapeutics (CORT) was upgraded by Truist Financial Corporation to "strong-buy".
Medium
Report
Corcept Therapeutics (CORT) was upgraded by Truist Financial Corporation to "strong-buy".
Date
Time
Symbol
Company Name
Action
%Chg
2/24/2026
04:05 pm
cort
corcept therapeutics incorporated
MISS
Report
-0.7%
corcept therapeutics incorporated
11/4/2025
04:05 pm
cort
corcept therapeutics incorporated
MISS
Report
7.8%
corcept therapeutics incorporated
7/31/2025
04:05 pm
cort
corcept therapeutics incorporated
BEAT
Report
2.7%
corcept therapeutics incorporated
5/5/2025
04:05 pm
cort
corcept therapeutics incorporated
IN-LINE
Report
-1.8%
corcept therapeutics incorporated
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/26
05:43 pm
cort
Form SCHEDULE 13G/A CORCEPT THERAPEUTICS Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A CORCEPT THERAPEUTICS Filed by: VANGUARD GROUP INC
3/25
03:49 pm
cort
Form 144 CORCEPT THERAPEUTICS Filed by: BELANOFF JOSEPH K
Low
Report
Form 144 CORCEPT THERAPEUTICS Filed by: BELANOFF JOSEPH K
3/25
01:32 pm
cort
Form 8-K CORCEPT THERAPEUTICS For: Mar 25
Low
Report
Form 8-K CORCEPT THERAPEUTICS For: Mar 25
3/24
04:56 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Mar 20 Filed by: WILSON JAMES N
High
Report
Form 4 CORCEPT THERAPEUTICS For: Mar 20 Filed by: WILSON JAMES N
3/24
04:55 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Mar 20 Filed by: Guyer William
High
Report
Form 4 CORCEPT THERAPEUTICS For: Mar 20 Filed by: Guyer William
3/19
05:07 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Mar 17 Filed by: BAKER G LEONARD JR
Low
Report
Form 4 CORCEPT THERAPEUTICS For: Mar 17 Filed by: BAKER G LEONARD JR
3/17
08:04 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Mar 13 Filed by: WILSON JAMES N
Low
Report
Form 4 CORCEPT THERAPEUTICS For: Mar 13 Filed by: WILSON JAMES N
3/17
07:52 pm
cort
Form 4 CORCEPT THERAPEUTICS For: Mar 13 Filed by: MAHONEY DAVID L
Low
Report
Form 4 CORCEPT THERAPEUTICS For: Mar 13 Filed by: MAHONEY DAVID L
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/1
Q2/2019 6/30/2019 EPS 0.250 ZacksConsensus 0.180 ActVsEst 0.070 - Beat
14.1%
11/8 Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 9.1%
4/17 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.4%
2/28 Form 4 CORCEPT THERAPEUTICS For: Feb 26 Filed by: BELANOFF JOSEPH K 4.8%
3/13 Form 8-K CORCEPT THERAPEUTICS For: Mar 12 3.1%
9/24 Corcept Therapeutics Incorporated (NASDAQ: CORT) is now covered by analysts at Jefferies Financial Group Inc. They set a "buy" rating on the stock. 3.0%
5/14 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at TheStreet from a "b" rating to a "c+" rating. 2.9%
11/7 Q3/2019 9/30/2019 EPS 0.310 ZacksConsensus 0.190 ActVsEst 0.120 - Beat 2.8%
5/23 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 2.7%
4/2 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 2.7%
11/8 Corcept Therapeutics' (CORT) CEO Joseph Belanoff on Q3 2019 Results - Earnings Call Transcript [Seeking Alpha] 9.1%
4/17 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "buy" rating to a "hold" rating. 5.4%
2/28 Form 4 CORCEPT THERAPEUTICS For: Feb 26 Filed by: BELANOFF JOSEPH K 4.8%
3/13 Form 8-K CORCEPT THERAPEUTICS For: Mar 12 3.1%
9/24 Corcept Therapeutics Incorporated (NASDAQ: CORT) is now covered by analysts at Jefferies Financial Group Inc. They set a "buy" rating on the stock. 3.0%
5/14 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at TheStreet from a "b" rating to a "c+" rating. 2.9%
11/7 Q3/2019 9/30/2019 EPS 0.310 ZacksConsensus 0.190 ActVsEst 0.120 - Beat 2.8%
5/23 Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 2.7%
4/2 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 2.7%
TOP News Decliners
3/5
Form 5 CORCEPT THERAPEUTICS For: Dec 31 Filed by: BAKER G LEONARD JR
-6.8%
3/13 Form 3 CORCEPT THERAPEUTICS For: Mar 12 Filed by: Alton Gregg H -6.4%
11/7 Corcept Therapeutics Incorporated (CORT) Q3 2019 Earnings Call Transcript [The Motley Fool] -5.4%
2/28 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.1%
5/9 Q1/2019 3/31/2019 EPS 0.200 ZacksConsensus 0.180 ActVsEst 0.020 - Beat -5.1%
1/30 Form 8-K CORCEPT THERAPEUTICS For: Jan 30 -4.6%
3/12 Corcept Therapeutics Appoints Gregg Alton to Board of Directors -4.4%
8/20 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at TheStreet from a "c+" rating to a "b" rating. -3.9%
4/27 Form DEF 14A CORCEPT THERAPEUTICS For: Apr 27 -3.5%
6/5 Form 4 CORCEPT THERAPEUTICS For: Jun 03 Filed by: BAKER G LEONARD JR -2.7%
3/13 Form 3 CORCEPT THERAPEUTICS For: Mar 12 Filed by: Alton Gregg H -6.4%
11/7 Corcept Therapeutics Incorporated (CORT) Q3 2019 Earnings Call Transcript [The Motley Fool] -5.4%
2/28 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -5.1%
5/9 Q1/2019 3/31/2019 EPS 0.200 ZacksConsensus 0.180 ActVsEst 0.020 - Beat -5.1%
1/30 Form 8-K CORCEPT THERAPEUTICS For: Jan 30 -4.6%
3/12 Corcept Therapeutics Appoints Gregg Alton to Board of Directors -4.4%
8/20 Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at TheStreet from a "c+" rating to a "b" rating. -3.9%
4/27 Form DEF 14A CORCEPT THERAPEUTICS For: Apr 27 -3.5%
6/5 Form 4 CORCEPT THERAPEUTICS For: Jun 03 Filed by: BAKER G LEONARD JR -2.7%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: